CND Life Sciences, Inc. is a pioneering medical technology company focused on developing diagnostic solutions for neurodegenerative diseases, particularly those related to abnormal protein accumulation in the nervous system. Their innovative approach centers around minimally invasive skin-based diagnostics aimed at improving the accuracy of diagnosing conditions like Parkinson’s disease and related disorders.
Company Values
The company stands out for its Syn-One Test®, the first commercially available test that detects misfolded alpha-synuclein proteins using simple skin biopsies.